Accelerating Access to Critical Therapies for ALS Act

Became Public Law No: 117-79.

Signed by President.

Presented to President.

Message on Senate action sent to the House.

Passed Senate without amendment by Voice Vote. (consideration: CR S9242)

Passed/agreed to in Senate: Passed Senate without amendment by Voice Vote.(consideration: CR S9242)

Received in the Senate, read twice.

Motion to reconsider laid on the table Agreed to without objection.

On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 423 - 3 (Roll no. 415). (text: CR H7509-7511)

Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 423 - 3 (Roll no. 415).(text: CR H7509-7511)

Considered as unfinished business. (consideration: CR H7535-7536)

At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.

DEBATE - The House proceeded with forty minutes of debate on H.R. 3537.

Considered under suspension of the rules. (consideration: CR H7509-7514)

Mr. Pallone moved to suspend the rules and pass the bill, as amended.

Placed on the Union Calendar, Calendar No. 148.

Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-207.

Ordered to be Reported (Amended) by Voice Vote.

Committee Consideration and Mark-up Session Held.

Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .

Subcommittee Consideration and Mark-up Session Held.

Referred to the Subcommittee on Health.

Referred to the House Committee on Energy and Commerce.

Introduced in House